Event Type
Disclosure
Mandatory
Variant
8-K
and Item 9.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Edgewise Therapeutics, Inc. dated February 26, 2026 104 Cover Pag